Inari Medical/NARI

$37.89

-0.11%
-
1D1W1MYTD1YMAX

About Inari Medical

Inari Medical, Inc. is a medical device company. The Company’s products primarily consist of ClotTriever and FlowTriever systems, which are catheter-based mechanical thrombectomy systems that are used for the treatment of the venous thromboembolism (VTE) deep vein thrombosis (DVT), and pulmonary embolism (PE). Its InThrill system is used for the removal of emboli and thrombi from the peripheral vasculature. The LimFlow system is indicated for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and are at risk of major amputation. It also offers RevCore thrombectomy catheter, which is a thrombectomy device for venous stent thrombosis, Triever 16 Curve catheter, which is used for venous thrombus removal, and ClotTriever Bold catheter, which is used for DVT and the removal of acute and chronic clots in the peripheral vasculature. Its ClotTriever XL, which is a catheter for efficient clot removal with minimal blood loss.

Ticker

NARI

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Andrew Hykes

Employees

1,300

Headquarters

Irvine, United States

Inari Medical Metrics

BasicAdvanced
$2.24B
Market cap
-
P/E ratio
-$0.03
EPS
0.93
Beta
-
Dividend rate
$2.24B
0.93033
$71.85
$37.92
1.18M
3.086
2.524
-0.28%
-0.37%
-0.31%
4.531
4.795
22.436
75.244
28.73%
94.22%
52.32%

What the Analysts think about Inari Medical

Analyst Ratings

Majority rating from 11 analysts.
Buy

Price Targets

Average projection from 11 analysts.
90.26% upside
High $100.00
Low $47.00
$37.89
Current price
$72.09
Average price target

Inari Medical Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-3.48% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$132M
4.51%
Net income
$-4.6M
-248.39%
Profit margin
-3.48%
-242.04%

Inari Medical Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 1,433.33%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$0.04
$0.04
$0.05
-$0.08
-
Expected
-$0.23
-$0.13
$0.00
$0.01
-$0.20
Surprise
-82.32%
-131.63%
1,025.11%
-1,433.33%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Inari Medical stock?

Inari Medical (NARI) has a market cap of $2.24B as of April 23, 2024.

What is the P/E ratio for Inari Medical stock?

The price to earnings (P/E) ratio for Inari Medical (NARI) stock is 0 as of April 23, 2024.

Does Inari Medical stock pay dividends?

No, Inari Medical (NARI) stock does not pay dividends to its shareholders as of April 23, 2024.

When is the next Inari Medical dividend payment date?

Inari Medical (NARI) stock does not pay dividends to its shareholders.

What is the beta indicator for Inari Medical?

Inari Medical (NARI) has a beta rating of 0.93. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Inari Medical stock price target?

The target price for Inari Medical (NARI) stock is $72.09, which is 94.05% above the current price of $37.15. This is an average based on projections from 11 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Inari Medical stock

Buy or sell Inari Medical stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing